Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.

Clinical breast cancer - 1 Feb 2017

Jasra Sakshi, Opyrchal Mateusz, Norton Larry, Mehta Rutika

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to Breast
Share to Carcinoma, Ductal, Breast
Share to Carcinoma, Intraductal, Noninfiltrating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mammography

Share to Positron Emission Tomography Computed Tomography

Share to Radiotherapy, Adjuvant

Share to Trastuzumab

Source

Identifiers

PMID: 27665021
DOI: 10.1016/j.clbc.2016.08.001

Genes

ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.PMID 27665021Read ↗

HER2 mutation status in Japanese HER2-positive breast cancer patients.Semantic proximity Read ↗

Prolonged Response to Trastuzumab in a Patient With HER2-Nonamplified Breast Cancer With Elevated HER2 Dimerization Harboring an<i>ERBB2</i>S310F MutationSemantic proximity Read ↗

The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as PertuzumabSemantic proximity Read ↗

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast CancerSemantic proximity Read ↗

Activating mutations in HER2: neu opportunities and neu challenges.Semantic proximity Read ↗

HER2 mutation status in Japanese HER2-negative breast cancer patients.Semantic proximity Read ↗

A review of HER2 overexpression and somatic mutations in cancers.Semantic proximity Read ↗

Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.